Fulcrum Therapeutics Inc (FULC)
R&D Expense Growth
-11.49%
Fiscal year · Period ending:
FULC R&D Expense Growth
Latest reported-11.49%period ending
Latest reported-11.49%period ending
FULC FY R&D Growth (YoY) (0.00% → -11.49%)
Latest values, visible window
High-resolution chart · PNG
FULC r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -11.4899% | |
| -11.7199% | |
| -6.4872% | |
| 10.1591% | |
| 18.0533% | |
| 35.9538% | |
| 72.4428% | |
| 36.1739% | |
| 0% |